Viridian Therapeutics, Inc.

NasdaqCM:VRDN Stock Report

Market Cap: US$1.1b

Viridian Therapeutics Future Growth

Future criteria checks 2/6

Viridian Therapeutics is forecast to grow earnings and revenue by 44.4% and 64.6% per annum respectively while EPS is expected to grow by 42.4% per annum.

Key information

44.4%

Earnings growth rate

42.4%

EPS growth rate

Biotechs earnings growth20.6%
Revenue growth rate64.6%
Future return on equityn/a
Analyst coverage

Good

Last updated09 Feb 2024

Recent future growth updates

Recent updates

Despite Lacking Profits Viridian Therapeutics (NASDAQ:VRDN) Seems To Be On Top Of Its Debt

Sep 12
Despite Lacking Profits Viridian Therapeutics (NASDAQ:VRDN) Seems To Be On Top Of Its Debt

Is There An Opportunity With Viridian Therapeutics, Inc.'s (NASDAQ:VRDN) 44% Undervaluation?

May 15
Is There An Opportunity With Viridian Therapeutics, Inc.'s (NASDAQ:VRDN) 44% Undervaluation?

Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?

Apr 18
Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?

Does Viridian Therapeutics (NASDAQ:VRDN) Have A Healthy Balance Sheet?

Jan 08
Does Viridian Therapeutics (NASDAQ:VRDN) Have A Healthy Balance Sheet?

Viridian: Excellent Early Data, Strong Cash, Great Strategy, Large Market

Sep 09

Viridian Therapeutics board compensation committee approves inducement grants

Sep 02

An Intrinsic Calculation For Viridian Therapeutics, Inc. (NASDAQ:VRDN) Suggests It's 49% Undervalued

Aug 22
An Intrinsic Calculation For Viridian Therapeutics, Inc. (NASDAQ:VRDN) Suggests It's 49% Undervalued

Viridian Therapeutics Q2 2022 Earnings Preview

Aug 12

Viridian Therapeutics gets a new COO

Jun 23

Viridian Therapeutics (VRDN) Investor Presentation - Slideshow

Jun 08

Viridian Therapeutics reports Q1 results

May 06

Earnings and Revenue Growth Forecasts

NasdaqCM:VRDN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026177-152N/A-1828
12/31/20256-274N/A-2259
12/31/20240-236N/A-20311
12/31/20230-224N/A-17411
9/30/20230-217-181-180N/A
6/30/20231-198-163-162N/A
3/31/20232-172-136-135N/A
12/31/20222-130-95-94N/A
9/30/20222-113-77-76N/A
6/30/20221-98-68-68N/A
3/31/20222-87-65-64N/A
12/31/20213-79-55-55N/A
9/30/20213-141-48-47N/A
6/30/20213-133-41-41N/A
3/31/20212-121-33-33N/A
12/31/20201-111-30-30N/A
9/30/20202-30-28-28N/A
6/30/20203-36-32-32N/A
3/31/20205-38-33-33N/A
12/31/20194-42-36-36N/A
9/30/20194-42-37-36N/A
6/30/20194-40-34-34N/A
3/31/20194-40-32-31N/A
12/31/20188-33-27-27N/A
9/30/20189-29-26-26N/A
6/30/201810-26-25-25N/A
3/31/20188-24-28-27N/A
12/31/20174-27-28-28N/A
9/30/20173-26-24-24N/A
6/30/20173-24N/A-21N/A
3/31/20173-21N/A-19N/A
12/31/20163-17N/A-15N/A
9/30/20164-17N/A-14N/A
12/31/20155-16N/A-13N/A
12/31/20148-6N/A-8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VRDN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: VRDN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: VRDN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: VRDN's revenue (64.6% per year) is forecast to grow faster than the US market (8.1% per year).

High Growth Revenue: VRDN's revenue (64.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if VRDN's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.